Purpose The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed increased effectiveness concerning lung function and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD) compared with the use of its mono-components. extrapolated to energy and survival, and treatment with tiotropiumColodaterol FDC was compared with tiotropium. CostCutility analysis was performed… Continue reading Purpose The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol